Search

686 Result(s)
Sort by

Uncommon_Mutations_Database

Uncommon_Mutations_Database

New database of published clinical outcomes from patients with uncommon EGFR mutations in advanced NSCLC treated with afatinib is available for global clinician use
Our Vision

Our Vision

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye.
Technologies

Technologies

We are expanding our global network of technology partners Learn more about partnering with us.
View from Both Sides of the Table

View from Both Sides of the Table

Scott DeWire, Global Head of Business Development & Licensing (BD&:L) shares experiences that have taught him first-hand the foundations of successful partnerships
Matthias Muenks

Matthias Muenks

Matthias Muenks, Global Engineering Process and Data Manager, speaks about our innovation and culture.
Dogs at work in Milan offices

Dogs at work in Milan offices

Dogs at work is a pilot project that allows pet-lover to bring their dogs to the office and enjoy the benefits they bring to their daily work life.
International Women's Day

International Women's Day

We celebrate International Women’s Day with this year’s UN Women motto being “Gender Equality Today for a Sustainable Tomorrow”
Rethinking mental health care

Rethinking mental health care

Outdated perceptions and practices fuelling mental health crisis, new Economist Impact study reveals
Data Science

Data Science

Revolutionizing research and development with data driven insights
More Green Overview

More Green Overview

Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects.
Avian influenza prevention at the source

Avian influenza prevention at the source

Teshome Mebatsion, Head of Viral Diseases Research at Boehringer Ingelheim, talks about the avian influenza virus, ways of prevention and scenarios for the future.
World Recycling Day: Closing the Loop

World Recycling Day: Closing the Loop

Transitioning the economy from a linear to a circular approach herculean task – but also an innovation that carries huge potential
Respiratory Diseases

Respiratory Diseases

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in respiratory diseases.